Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sunshine Biopharma 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 USA

https://sunshinebiopharma.com Employees: 52 P: 954-330-0684

Sector:

Medical

Description:

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

Key Statistics

Overview:

Market Capitalization, $K 5,887
Enterprise Value, $K -3,793
Shares Outstanding, K 4,906
Float, K 4,904
% Float 99.96%
Short Interest, K 281
Short Float 5.73%
Days to Cover 8.13
Short Volume Ratio 0.06
% of Insider Shareholders 0.04%
% of Institutional Shareholders 41.98%

Financials:

Annual Sales, $ 34,870 K
Annual Net Income, $ -5,130 K
Last Quarter Sales, $ 9,420 K
Last Quarter Net Income, $ -880 K
EBIT, $ -4,610 K
EBITDA, $ -4,390 K

Growth:

1-Year Return -46.90%
3-Year Return -99.93%
5-Year Return -100.00%
5-Year Revenue Growth 174,250.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 11/13/25
Next Earnings Date 04/07/26
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr 51.28%
EPS Growth vs. Prev Year 79.79%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 08/08/24

SBFM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.96%
Return-on-Assets % -19.46%
Profit Margin % -14.71%
Debt/Equity 0.00
Price/Sales 0.11
Price/Cash Flow N/A
Price/Book 0.24
Book Value/Share 4.93
Interest Coverage -536.00
60-Month Beta 1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar